These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 29709361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
    Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T.
    J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
    [Abstract] [Full Text] [Related]

  • 4. High-dose heparin is associated with higher bleeding and thrombosis rates in pediatric patients following cardiac surgery.
    Vorisek CN, Sleeper LA, Piekarski B, Lu M, Rogers J, Oladunjoye OO, Emani SM.
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1199-1206. PubMed ID: 31399238
    [Abstract] [Full Text] [Related]

  • 5. Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels.
    Schechter T, Finkelstein Y, Ali M, Kahr WH, Williams S, Chan AK, Deveber G, Brandão LR.
    J Thromb Haemost; 2012 Mar; 10(3):368-74. PubMed ID: 22244010
    [Abstract] [Full Text] [Related]

  • 6. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D, Långström S, Petäjä J, Heikinheimo M, Pihkala J.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1174-9. PubMed ID: 22915548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time.
    Kindelin NM, Anthes AM, Providence SM, Zhao X, Aspinall SL.
    Ann Pharmacother; 2021 May 01; 55(5):575-583. PubMed ID: 32964730
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The PiCT® test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study.
    Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W.
    J Thromb Haemost; 2016 Nov 01; 14(11):2187-2193. PubMed ID: 27582411
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.
    Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Lau A, Mitchell LG.
    Haematologica; 2007 Apr 01; 92(4):554-7. PubMed ID: 17488668
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW, Vondracek TG.
    Pharmacotherapy; 2012 Jun 01; 32(6):546-58. PubMed ID: 22531940
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.